Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Lymphedema 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Atrophy 1

Interventions

pembrolizumab 3talimogene laherparepvec 1spartalizumab 1nanocis 1fludarabine 1avelumab 1atezolizumab 1aldesleukin 1Technetium-99 1TTI-621 1Radiation 1Proton Pump Inhibitors 1Nivolumab 1Lasers 1Ipilimumab 1Interleukin-2 1Infracyanine green 1Indocyanine Green 1Hydrocortisone 1Cyclophosphamide 1Bleomycin 1Antineoplastic Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Lasers × Breast × Clear all
NCT01872923 2014-06-16

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

PCI Biotech AS

Phase 1 Completed
3 enrolled
BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡